A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy
A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy
About this item
Full title
Author / Creator
Publisher
Cell Press
Journal title
Language
English
Formats
Publication information
Publisher
Cell Press
Subjects
More information
Scope and Contents
Contents
The industrial development of active immunotherapy based on live-attenuated bacterial vectors has matured. We developed a microsyringe for antigen delivery based on the type III secretion system (T3SS) of P. aeruginosa. We applied the "killed but metabolically active" (KBMA) attenuation strategy to make this bacterial vector suitable for human use....
Alternative Titles
Full title
A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03021548v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03021548v1
Other Identifiers
ISSN
1525-0016
E-ISSN
1525-0024
DOI
10.1038/mt.2013.41
